Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Amphastar Pharmaceuticals, Inc. (AMPH)  
$42.25 0.08 (0.19%) as of 4:30 Mon 6/3


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 47,500,000
Market Cap: 2.01(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $38.65 - $65
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 31,636 387,836 590,546 794,601
Total Sell Value $1,475,158 $21,735,076 $32,576,849 $40,646,784
Total People Sold 3 5 8 10
Total Sell Transactions 4 11 26 62
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 956
  Page 25 of 39  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Luo Mary Z. COO, Chief Scientist, Chairman   •       •       •   2018-03-15 4 A $0.00 $0 D/D 98,029 2,111,194     -
   Shandell Jason B. President and General Counsel   •       •      –    2018-03-15 4 A $0.00 $0 D/D 39,919 256,867     -
   Prins Richard K Director   –       •      –    2018-03-15 4 S $19.90 $330,318 D/D (16,598) 28,844     -
   Prins Richard K Director   –       •      –    2018-03-15 4 OE $14.66 $243,327 D/D 16,598 45,442     -
   Peters William J CFO, SVP & Treasurer   •       –      –    2018-03-15 4 A $0.00 $0 D/D 22,359 100,673     -
   Shandell Jason B. President and General Counsel   •       •      –    2018-03-14 4 AS $20.45 $8,180 D/D (400) 216,948     -
   Shandell Jason B. President and General Counsel   •       •      –    2018-03-14 4 OE $11.79 $4,716 D/D 400 217,348     -
   Shandell Jason B. President and General Counsel   •       •      –    2018-03-13 4 AS $20.45 $6,135 D/D (300) 216,948     -
   Shandell Jason B. President and General Counsel   •       •      –    2018-03-13 4 OE $11.79 $3,537 D/D 300 217,248     -
   Peters William J CFO, SVP & Treasurer   •       –      –    2018-03-13 4 AS $20.10 $398,004 D/D (19,801) 78,314     -
   Peters William J CFO, SVP & Treasurer   •       –      –    2018-03-13 4 OE $11.33 $224,345 D/D 19,801 98,115     -
   Shandell Jason B. President and General Counsel   •       •      –    2018-01-26 4 AS $19.56 $194,925 D/D (9,966) 216,948     -
   Shandell Jason B. President and General Counsel   •       •      –    2018-01-25 4 AS $19.26 $166,822 D/D (8,661) 226,914     -
   Gerst Diane G. EVP, QA & Regulatory Affairs   •       –      –    2017-12-19 4 AS $19.48 $10,186 D/D (523) 30,164     -
   Luo Mary Z. COO, Chief Scientist/Chairman   •       •       •   2017-12-15 4 D $19.30 $5,902,384 I/I (305,823) 1,330,646     -
   Luo Mary Z. COO, Chief Scientist/Chairman   •       •       •   2017-12-15 4 OE $12.02 $4,485,673 I/I 373,091 1,636,469     -
   Luo Mary Z. COO, Chief Scientist/Chairman   •       •       •   2017-12-15 4 D $19.30 $10,118,334 D/D (524,266) 2,013,165     -
   Luo Mary Z. COO, Chief Scientist/Chairman   •       •       •   2017-12-15 4 OE $12.02 $7,689,718 D/D 639,584 2,537,431     -
   Shohet Stephen B. Director   –       •      –    2017-12-14 4 AS $18.87 $148,430 D/D (7,866) 24,116     -
   Shohet Stephen B. Director   –       •      –    2017-12-14 4 OE $10.77 $84,717 D/D 7,866 31,982     -
   Gerst Diane G. EVP, QA & Regulatory Affairs   •       –      –    2017-12-12 4 AS $18.96 $9,917 D/D (523) 30,687     -
   Shohet Stephen B. Director   –       •      –    2017-12-07 4 AS $18.34 $144,210 D/D (7,862) 24,116     -
   Shohet Stephen B. Director   –       •      –    2017-12-07 4 OE $10.77 $84,674 D/D 7,862 31,978     -
   Peters William J CFO, SVP & Treasurer   •       –      –    2017-12-01 4 AS $19.67 $122,465 D/D (6,226) 78,314     -
   Shohet Stephen B. Director   –       •      –    2017-11-30 4 AS $19.25 $151,344 D/D (7,862) 24,116     -
  956 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 25 of 39
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us